Although SP-A was detectable in tumour cells from heterozygous patients, transfection of A549 cells with any of the mutated SFTPA2 variants revealed poor protein expression, in contrast to the cells transfected with wild-type gene. The gene discussed is SFTPA2; the disease is neoplasm.